Neoxaline
Antimitotic. Cell cycle inhibitor at the G2/M phase. Antiproliferative. Weak CNS stimulant with weak inhibitory activity on blood platelet aggregation. Mycotoxin.
| Catalog Number | AG-CN2-0154-M001 |
| Alternative Name(s) | Nedoxaline; BRN 5669473 |
| Research Area | Cancer, Cell Death, Natural Products, Neurobiology |
| Molecular Formula | C23H25N5O4 |
| CAS# | 71812-10-7 |
| Purity | >97% |
| Inchi | InChI=1S/C23H25N5O4/c1-5-21(2,3)22-11-18(29)20(31)27-17(10-14-12-24-13-25-14)19(30)26-23(22,27)28(32-4)16-9-7-6-8-15(16)22/h5-10,12-13,18,29H,1,11H2,2-4H3,(H,24,25)(H,26,30)/b17-10+ |
| Inchi Key | HHLNXXASUKFCCX-LICLKQGHSA-N |
| SMILES | CON1C2=C(C=CC=C2)C2(CC(O)C(=O)N3C(=CC4=CNC=N4)C(=O)NC123)C(C)(C)C=C |
| Size | 1 mg |
| Supplier Page | http://www.adipogen.com/ag-cn2-0154/neoxaline.html |